• Aucun résultat trouvé

Addiction medicine and substance abuse care

N/A
N/A
Protected

Academic year: 2022

Partager "Addiction medicine and substance abuse care"

Copied!
1
0
0

Texte intégral

(1)

Vol 57: NoVEMBER • NoVEMBRE 2011

|

Canadian Family PhysicianLe Médecin de famille canadien

e429

Web exclusive | Fast Facts

U

nfortunately, the need for addiction medicine and substance abuse care is still a considerable part of the Canadian health care system. A recent study esti- mated the prevalence of substance abuse among the Canadian population to be 11%.1 According to data from the 2010 National Physician Survey (NPS), 30%

of Canadian FPs and GPs offer substance abuse care, with 3% identifying it as the area of focus for their prac- tices. Addictions are also a considerable problem for the Canadian population. Sixty-nine percent of FPs and GPs report seeing patients with addictions, and 4% of physi- cians report that patients with addictions represent 10%

or more of their patient populations. Among the family medicine residents who responded to the 2010 NPS, 48%

indicated that they intended to provide care for patients with substance abuse problems.

Table 1 shows the distribution of FPs who indicated that they provided care for patients with addictions. It is evident that addictions know few boundaries and are prevalent across all kinds of practice populations, especially in rural and remote areas. Among the prov- inces (Table 2), the highest proportions of FPs caring for patients with addictions are reported in Saskatchewan (78%) and British Columbia (77%), while Quebec (54%) and Newfoundland (65%) have the lowest proportions.

The important role that FPs play in substance abuse care should be recognized and further studied to ensure proper training and information are in place for physicians to provide the necessary care to the Canadian public.

The NPS is a collaborative project of the College of Family Physicians of Canada, the Canadian Medical Association, and the Royal College of Physicians and Surgeons of Canada. Additional results are available at www.nationalphysiciansurvey.ca. If you would like the opportunity to develop and write a future Fast Fact using the NPS results, please contact Artem Safarov, National Physician Survey Project Manager, at 800 387-6197, extension 242, or artem@cfpc.ca.

Reference

1. Veldhuizen S, Urbanoski K, Cairney J. Geographical variation in the prevalence of problematic substance use in Canada. Can J Psychiatry 2007;52(7):426-33.

Addiction medicine and substance abuse care

Table 1. Proportion of FPs who provide care for patients with addictions by practice population they serve

PRACTICE POPULATION FPs, %

Inner city 65

Urban or suburban 67

Small town 74

Rural 76

Isolated or remote 76

Other 60

Cannot identify 61

Total 69

Table 2. Proportion of FPs providing care for patients with addictions, by province*

PROVINCE

FPs PROVIDING CARE FOR PATIENTS WITH ADDICTIONS, %

FPs FOR WHOM PATIENTS WITH ADDICTIONS REPRESENT 10%

OR MORE OF THE PATIENT POPULATION, %

Newfoundland 65 3

Prince Edward Island 76 4

Nova Scotia 74 3

New Brunswick 73 4

Quebec 54 3

Ontario 71 3

Manitoba 73 4

Saskatchewan 78 9

Alberta 74 5

British Columbia 77 6

Canada 69 4

*Data for the Territories are not given owing to a small number of responses.

Références

Documents relatifs

News reports regarding substance abuse cases reported in online edition of popular Malayalam news papers are used for this purpose.. These are then pro- cessed using Natural

Advance care planning allows patients to assert their values and priorities for care throughout their disease course and throughout their lifespan, so that when unex-

Our leadership, the College of Family Physicians of Canada and the provincial chapters, should begin by stating that they will not endorse guidelines targeting primary care unless

Furthermore, having guidelines developed separately by specialists and family physicians creates the potential risk of contradictory recommendations or debates that can do

• Managing pain in a patient with a life-limiting illness and a history of substance abuse is complicated and challenging, especially as use of controlled substances might

It includes patients known to have died, stopped treatment for medical reasons and registered as so in the clinic, in addition to patients LTFU whose outcome is unknown..

Annex 2 Burden attributable to mental, neurological, and substance use disorders and the available human resources in countries with low and lower middle

The information we now have- concerning the spreading epidemic of tobacco use, the health conse- quences of alcohol use in the devel- oping world, the increasing use of